Description Gemtuzumab Ozogamicin, marketed under the brand name MYLOTARG, It is an prescription medication that has been approved gemtuzumab ozogamicin (Mylotarg) on September 1, 2017. It is used to treat: Newly diagnosed CD33-positive acute myeloid leukemia (AML) in adults Relapsed or refractory CD33-positive AML in adults and in pediatric patients 2 years and older. What is MYLOTARG (gemtuzumab ozogamicin) ? MYLOTARG is a CD33-directed antibody-drug conjugate indicated for: treatment of newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults. treatment of relapsed or refractory CD33-positive AML in adults and in pediatric patients 2 years and older How to order approved “MYLOTARG (gemtuzumab ozogamicin) for injection” Medicine? MYLOTARG (Gemtuzumab Ozogamicin) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing MYLOTARG and arranging delivery to your location, please get in touch with Mr. Rakesh at 91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
